Deutsche Bank’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Hold |
224,846
| – | – | ﹤0.01% | 3130 |
|
|
2025
Q1 | $60.7K | Hold |
224,846
| – | – | ﹤0.01% | 3310 |
|
|
2024
Q4 | $117K | Hold |
224,846
| – | – | ﹤0.01% | 3211 |
|
|
2024
Q3 | $729K | Hold |
224,846
| – | – | ﹤0.01% | 2231 |
|
|
2024
Q2 | $675K | Hold |
224,846
| – | – | ﹤0.01% | 2158 |
|
|
2024
Q1 | $1.05M | Hold |
224,846
| – | – | ﹤0.01% | 1967 |
|
|
2023
Q4 | $931K | Buy |
224,846
+219,887
| +4,434% | +$910K | ﹤0.01% | 2032 |
|
|
2023
Q3 | $14.9K | Sell |
4,959
-233,338
| -98% | -$700K | ﹤0.01% | 3486 |
|
|
2023
Q2 | $586K | Sell |
238,297
-16,445
| -6% | -$40.5K | ﹤0.01% | 2266 |
|
|
2023
Q1 | $576K | Buy |
254,742
+15,567
| +7% | +$35.2K | ﹤0.01% | 2411 |
|
|
2022
Q4 | $835K | Buy |
239,175
+1,869
| +0.8% | +$6.52K | ﹤0.01% | 2151 |
|
|
2022
Q3 | $8.79M | Sell |
237,306
-1,827
| -0.8% | -$67.6K | 0.01% | 999 |
|
|
2022
Q2 | $4.54M | Buy |
239,133
+560
| +0.2% | +$10.6K | ﹤0.01% | 1334 |
|
|
2022
Q1 | $6.44M | Buy |
238,573
+228,414
| +2,248% | +$6.16M | ﹤0.01% | 1280 |
|
|
2021
Q4 | $229K | Sell |
10,159
-6,322
| -38% | -$143K | ﹤0.01% | 3286 |
|
|
2021
Q3 | $432K | Buy |
16,481
+820
| +5% | +$21.5K | ﹤0.01% | 3126 |
|
|
2021
Q2 | $501K | Sell |
15,661
-357
| -2% | -$11.4K | ﹤0.01% | 3204 |
|
|
2021
Q1 | $563K | Buy |
16,018
+4,411
| +38% | +$155K | ﹤0.01% | 3008 |
|
|
2020
Q4 | $371K | Buy |
11,607
+3,790
| +48% | +$121K | ﹤0.01% | 3077 |
|
|
2020
Q3 | $294K | Buy |
7,817
+681
| +10% | +$25.6K | ﹤0.01% | 2951 |
|
|
2020
Q2 | $320K | Buy |
+7,136
| New | +$320K | ﹤0.01% | 2845 |
|